Cardiovascular Diseases (CVD) Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Cardiovascular Diseases (CVD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

HealthyObesity, OverweightChronic Kidney Disease+3 more
Chang Gung Memorial Hospital6,266 enrolled1 locationNCT07248371
Recruiting

The HELlenic Thoracic Society Initiative for CΟPD and CVD

Chronic Obstructive Pulmonary Disease (COPD)Cardiovascular Diseases (CVD)
Hellenic Thoracic Society900 enrolled2 locationsNCT06595784
Recruiting

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

Obesity and OverweightMetabolic SyndromeHypertension+7 more
Shanghai Changzheng Hospital4,094 enrolled1 locationNCT07043166
Recruiting
Not Applicable

Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk

StressBlood PressureCardiovascular Diseases (CVD)
University of Alabama at Birmingham48 enrolled1 locationNCT06811896
Recruiting

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Chronic Kidney DiseasesType 2 DiabetesObesity (Disorder)+2 more
Asfendiyarov Kazakh National Medical University6,720 enrolled1 locationNCT06953180
Recruiting
Not Applicable

Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)

Cardiovascular Diseases (CVD)Depression Anxiety Disorder
Guangdong Provincial People's Hospital106 enrolled1 locationNCT07025590
Recruiting
Phase 1Phase 2

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients

Cardiovascular Diseases (CVD)Kidney Failure, ChronicMalnutrition-Inflammation Syndrome+1 more
Mansoura University46 enrolled1 locationNCT06903559
Recruiting
Not Applicable

Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension

HypertensionInflammationCardiovascular Diseases (CVD)
Universidade Federal Fluminense34 enrolled1 locationNCT06917131